Pedunculopontine nucleus deep brain stimulation in a patient with primary progressive freezing gait disorder.
Stereotact Funct Neurosurg., 88(1):51-5 (2010)
Parkinsonism in patients with a history of amphetamine exposure.
Mov. Disord., Jan;25(2):228-31 (2010)
Qualitative imaging of adeno-associated virus serotype 2-human aromatic L-amino acid decarboxylase gene therapy in a phase I study for the treatment of Parkinson disease.
Neurosurgery., Nov;67(5):1377-85 (2010)
Development of Parkinson's disease in patients with Narcolepsy.
J Neural Transm., Jun;119(6):697-9 (2012)
Long-term evaluation of a phase 1 study of AADC gene therapy for Parkinson's disease.
Hum. Gene Ther., Apr;23(4):377-81 (2012)
Implantation of deep brain stimulators into the subthalamic nucleus: technical approach and magnetic resonance imaging-verified lead locations.
J. Neurosurg., Aug;97(2):370-87 (2002)
Clinical differentiation of parkinsonian syndromes: prognostic and therapeutic relevance.
Am. J. Med., Sep;117(6):412-9 (2004)
Safety and tolerability of putaminal AADC gene therapy for Parkinson disease.
Neurology., Nov;73(20):1662-9 (2009)
Cognitive and neuropsychiatric profile of the synucleinopathies: Parkinson disease, dementia with Lewy bodies, and multiple system atrophy.
Alzheimer Dis Assoc Disord., 23(4):365-70 (2009)
Acute brain injury, NMDA receptors, and hydrogen ions: observations in cortical cell cultures.
Adv. Exp. Med. Biol., 268:501-4 (1990)
Magnesium removal induces paroxysmal neuronal firing and NMDA receptor-mediated neuronal degeneration in cortical cultures.
Neurosci. Lett., Jul;115(2-3):313-7 (1990)
Effects of unilateral subthalamic and pallidal deep brain stimulation on fine motor functions in Parkinson's disease.
Mov. Disord., Apr;22(5):619-26 (2007)
Results from a phase I safety trial of hAADC gene therapy for Parkinson disease.
Neurology., May;70(21):1980-3 (2008)
The neurophysiology and effect of deep brain stimulation in a patient with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism.
J. Neurosurg., Feb;110(2):234-8 (2009)
Glutamate neurotoxicity, calcium, and zinc.
Ann. N. Y. Acad. Sci., 568:219-24 (1989)
Bicarbonate dependence of glutamate receptor activation by beta-N-methylamino-L-alanine: channel recording and study with related compounds.
Neuron., Sep;3(3):321-6 (1989)
Effect of zinc on NMDA receptor-mediated channel currents in cortical neurons.
J. Neurosci., Jan;10(1):108-16 (1990)
A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease.
Neurology., Apr;78(16):1229-36 (2012)